Marinus Pharmaceuticals Inc. Common Stock is a biopharmaceutical company that focuses on developing and commercializing innovative therapeutics to treat epilepsy and other neurological disorders. Their cutting-edge research and development efforts have resulted in promising therapies that have the potential to significantly improve the lives of patients suffering from these debilitating conditions.
